Fig. 1 · Structure
Documents & Downloads
CDK-IN-6
CDK Inhibitor
CDK-IN-6 is a pyrazolo[1,5-a]pyrimidine compound that functions as a cyclin-dependent kinase (CDK) inhibitor. This compound exhibits significant anticancer activity by hindering cell cycle progression, particularly in malignant cells. CDK-IN-6 is utilized in research to explore pathways involved in cancer proliferation and may serve as a valuable tool for investigating therapeutic strategies targeting CDK regulation in various tumors.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 779353-02-5 |
| Applications | CDK Inhibitor |
| Formula | C21H28N6O |
| Molecular Weight | 380.49 |
| SMILES | CCC1=C2N(N=C1)C(NCC3=CN=CC=C3)=CC(N(CCCC4)[C@@H]4CCO)=N2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.